Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1968 1
1969 1
1970 2
1972 1
1978 1
1982 1
1989 1
1997 1
2000 1
2002 1
2003 2
2004 4
2006 1
2007 4
2009 2
2010 1
2011 2
2012 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Familial myoclonus.
Stuart WH, Schwartz JF, Mayer WB, Karp HE. Stuart WH, et al. Neurology. 1968 Mar;18(3):302. Neurology. 1968. PMID: 5690405 No abstract available.
Stepped-care approach to treating MS: a managed care treatment algorithm.
Rich SR, Coleman IC, Cook R, Hum DS, Johnson B, Maves T, Mazanec WJ, Miller JR, Proveaux WJ, Rossman HS, Stuart WH. Rich SR, et al. Among authors: stuart wh. J Manag Care Pharm. 2004 Jun;10(3 Suppl B):S26-32. doi: 10.18553/jmcp.2004.10.S5-A.S26. J Manag Care Pharm. 2004. PMID: 15253687 Free PMC article. Review.
Concomitant therapy for multiple sclerosis.
Stuart WH, Vermersch P. Stuart WH, et al. Neurology. 2004 Dec 14;63(11 Suppl 5):S28-34. doi: 10.1212/wnl.63.11_suppl_5.s28. Neurology. 2004. PMID: 15596733 Review.
L-dopa and parkinsonism.
Stuart WH. Stuart WH. J Med Assoc Ga. 1970 Aug;59(8):331-2. J Med Assoc Ga. 1970. PMID: 5451035 No abstract available.
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Rudick RA, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Radue EW, Lublin FD, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA, Sandrock AW; SENTINEL Investigators. Rudick RA, et al. Among authors: stuart wh. N Engl J Med. 2006 Mar 2;354(9):911-23. doi: 10.1056/NEJMoa044396. N Engl J Med. 2006. PMID: 16510745 Free article. Clinical Trial.
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis.
Balcer LJ, Galetta SL, Calabresi PA, Confavreux C, Giovannoni G, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA. Balcer LJ, et al. Among authors: stuart wh. Neurology. 2007 Apr 17;68(16):1299-304. doi: 10.1212/01.wnl.0000259521.14704.a8. Neurology. 2007. PMID: 17438220 Clinical Trial.
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS.
Weinstock-Guttman B, Galetta SL, Giovannoni G, Havrdova E, Hutchinson M, Kappos L, O'Connor PW, Phillips JT, Polman C, Stuart WH, Lynn F, Hotermans C. Weinstock-Guttman B, et al. Among authors: stuart wh. J Neurol. 2012 May;259(5):898-905. doi: 10.1007/s00415-011-6275-7. Epub 2011 Oct 19. J Neurol. 2012. PMID: 22008873 Clinical Trial.
28 results